Methylation-associated silencing of TU3A in human cancers

International Journal of Oncology

Volumn 33, Issue 4, 2008, Pages 893-899

  Awakura, Yasuo ^a   Nakamura, Eijiro ^a   Ito, Noriyuki ^a   Kamoto, Toshiyuki ^a   Ogawa, Osamu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; DNA methylation; Renal cell carcinoma; TU3A

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; MESSENGER RNA; PROTEIN TU3A; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; EPIGENETICS; FEMALE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; SEQUENCE ANALYSIS; TESTIS CANCER; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; NUCLEAR PROTEINS;

EID: 54049157432     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo_00000078     Document Type: Article

References (24)

1. Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA and van Kessel AG: Understanding familial and non-familial renal cell cancer. Hum Mol Genet 11: 2489-2498, 2002.
2. Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T and Yoshida O: Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res 51: 949-953, 1991.
3. Kondo K, Yao M, Yoshida M, Kishida T, Shuin T, Miura T, Moriyama M, Kobayashi K, Sakai N, Kaneko S, Kawakami S, Baba M, Nakaigawa N, Nagashima Y, Nakatani Y and Hosaka M: Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Genes Chromosomes Cancer 34: 58-68, 2002.
4. Brauch H, Weirich G, Brieger J, Glavac D, Rodl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Storkel S, Rotter M, Masera A, Gugeler N and Decker HJ: VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot-spot mutation. Cancer Res 60: 1942-1948, 2000.
5. Hamano K, Esumi M, Igarashi H, Chino K, Mochida J, Ishida H and Okada K: Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma. J Urol 167: 713-717, 2002.
6. Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F and Maher ER: Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 61: 7277-7281, 2001.
7. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G and Zabarovsky ER: The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98: 7504-7509, 2001.
8. Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD and Latif F: Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 22: 1580-1588, 2003.
9. Yamato T, Orikasa K, Fukushige S, Orikasa S and Horii A: Isolation and characterization of the novel gene, TU3A, in a commonly deleted region on 3p14.3→p14.2 in renal cell carcinoma. Cytogenet Cell Genet 87: 291-295, 1999.
10. Wang L, Darling J, Zhang JS, Liu W, Qian J, Bostwick D, Hartmann L, Jenkins R, Bardenhauer W, Schutte J, Opalka B and Smith DI: Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chromosomes Cancer 27: 1-10, 2000.
11. Kristiansen G, Pilarsky C, Wissmann C, Kaiser S, Bruemmendorf T, Roepcke S, Dahl E, Hinzmann B, Specht T, Pervan J, Stephan C, Loening S, Dietel M and Rosenthal A: Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J Pathol 205: 359-376, 2005.
12. Vanaja DK, Ballman KV, Morlan BW, Cheville JC, Neumann RM, Lieber MM, Tindall DJ and Young CY: PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. Clin Cancer Res 12: 1128-1136, 2006.
13. Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, Coppola D, Kruhoffer M, Aaltonen L, Orntoft TF, Quackenbush J and Yeatinan TJ: Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol 23: 3526-3535, 2005.
14. Fathallah-Shaykh HM, Rigen M, Zhao LJ, Bansal K, He B, Engelhard HH, Cerullo L, Roenn KV, Byrne R, Munoz L, Rosseau GL, Glick R, Lichtor T and Di Savino E: Mathematical modeling of noise and discovery of genetic expression classes in gliomas. Oncogene 21: 7164-7174, 2002.
15. Van den Boom J, Wolter M, Blaschke B, Knobbe CB and Reifenberger G: Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. Int J Cancer 119: 2330-2338, 2006.
16. Goldstein NS: Grading of renal cell carcinoma. Urol Clin North Am 26: 637-642, 1999.
17. Ozdemir E, Kakehi Y, Nakamura E, Kinoshita H, Terachi T, Okada Y and Yoshida O: HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma. Cancer Res 57: 742-746, 1997.
18. Brena RM, Auer H, Kornacker K, Hackanson B, Raval A, Byrd JC and Plass C: Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform. Nucleic Acids Res 34: e17, 2006.
19. Scherf M, Klingenhoff A and Werner T: Highly specific localization of promoter regions in large genomic sequences by PromoterInspector: a novel context analysis approach. J Mol Biol 297: 599-606, 2000.
20. Chen S, Zhu B and Yu L: In silico comparison of gene expression levels in ten human tumor types reveals candidate genes associated with carcinogenesis. Cytogenet Genome Res 112: 53-59, 2006.
21. Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Job K and Mukai T: The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. J Biochem 137: 431-440, 2005.
22. Shimazui T, Oosterwijk E, Debruyne FM and Schalken JA: Molecular prognostic factor in renal cell carcinoma. Semin Urol Oncol 14: 250-255, 1996.
23. Spira A, Beane J, Shah V, Liu G, Schembri F, Yang X, Palma J and Brody JS: Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 101: 10143-10148, 2004.
24. Lupas A: Coiled coils: new structures and new functions. Trends Biochem Sci 21: 375-382, 1996.